Inoval en es it fr

Inoval Brand names, Inoval Analogs

Inoval Brand Names Mixture

  • No information avaliable

Inoval Chemical_Formula

C10H16NO+

Inoval RX_link

http://www.rxlist.com/cgi/generic3/edrophonium.htm

Inoval fda sheet

Inoval msds (material safety sheet)

Inoval MSDS

Inoval Synthesis Reference

No information avaliable

Inoval Molecular Weight

166.24 g/mol

Inoval Melting Point

No information avaliable

Inoval H2O Solubility

Appreciable as liquid hydrochloride salt

Inoval State

Liquid

Inoval LogP

-2.95

Inoval Dosage Forms

Liquid for injection

Inoval Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Inoval Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Inoval Absorption

Rapidly absorbed.

Inoval side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Inoval Patient Information

No information avaliable

Inoval Organisms Affected

Humans and other mammals